Symbol="KDNY"
AssetType="Common Stock"
Name="Chinook Therapeutics Inc"
Description="Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision drugs for kidney disease. The company is headquartered in Seattle, Washington."
CIK="1435049"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="740 HEINZ AVENUE, BERKELEY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2630352000"
EBITDA="-197027008"
PERatio="None"
PEGRatio="None"
BookValue="6.17"
DividendPerShare="0"
DividendYield="0"
EPS="-3.23"
RevenuePerShareTTM="0.078"
ProfitMargin="0"
OperatingMarginTTM="-38.44"
ReturnOnAssetsTTM="-0.235"
ReturnOnEquityTTM="-0.516"
RevenueTTM="5259000"
GrossProfitTTM="-135083000"
DilutedEPSTTM="-3.23"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.322"
AnalystTargetPrice="39.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.9"
PriceToBookRatio="3.057"
EVToRevenue="19.67"
EVToEBITDA="-11.5"
Beta="0.683"
num_52WeekHigh="39.44"
num_52WeekLow="17.72"
num_50DayMovingAverage="29.95"
num_200DayMovingAverage="24.48"
SharesOutstanding="67050000"
DividendDate="2020-10-02"
ExDividendDate="None"
symbol="KDNY"
open="39.38"
high="39.54"
low="39.33"
price="39.35"
volume="924796.00"
latest_trading_day="2023-07-18"
previous_close="39.38"
change="-0.03"
change_percent="-0.0762%"
aroon_positive_momentum_days="37"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="1124220"
Change_recent_avg="0.02"
Delta_recent_avg="0.86"
Variance_recent_avg="0.43"
Change_ratio_recent_avg="0.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="1135"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0168.jpeg"
image_negative_thumbnail_id_2="163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0013.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="673"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0035.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
